This groundbreaking study, funded by a $2.78 million grant from the National Institutes of Health and National Cancer Institute, brings together researchers from Case Western Reserve University, Cleveland Clinic, and University Hospitals to harness the power of artificial intelligence (AI) in revolutionizing the treatment of rectal cancer patients. With rectal cancer being the third most common type of cancer in the digestive system, this research aims to develop new radiomic signatures using AI-driven analysis of medical images to accurately determine how well patients respond to therapy. By doing so, clinicians will be able to personalize treatments, reducing unnecessary surgeries and associated complications. The study’s innovative approach has the potential to bring significant survival and quality-of-life benefits to rectal cancer patients, marking a major step forward in cancer care. The collaboration between medical institutions and disciplines is a testament to the power of interdisciplinary research in driving meaningful change.
AI-Powered Cancer Care
Researchers will analyze medical images from over 900 rectal cancer patients using AI to develop a non-invasive and accurate method to identify patients with no tumor remaining after therapy.
1–2 minutes
TOP STORIES
CERT-In reported that AI agents accessed sensitive data in Indian organizations during testing phases …
Flock’s gunshot detection technology faces backlash amid privacy concerns …
OpenAI has alerted the FBI after an employee allegedly planted a hidden recording device in an executive conference room …
Character.AI’s bankruptcy filing reveals the challenges of scaling AI products …
Meta’s new Muse Wonder models promise enhanced capabilities and memory retention for personal AI assistants …
Apple is tightening privacy controls on macOS to protect users from AI risks …
